Apaf-1 plays a critical role in apoptosis by binding to and activating procaspase-9. We have identified a novel Apaf-1 cDNA encoding a protein of 1248 amino acids containing an insertion of 11 residues between the CARD and ATPase domains, and another 43 amino acid insertion creating an additional WD-40 repeat. The product of this Apaf-1 cDNA activated procaspase-9 in a cytochrome c and dATP/ATP-dependent manner. We used this Apaf-1 to show that Apaf-1 requires dATP/ATP hydrolysis to interact with cytochrome c, self-associate and bind to procaspase-9. A P-loop mutant (Apaf-1K160R) was unable to associate with Apaf-1 or bind to procaspase-9. Mutation of Met368 to Leu enabled Apaf-1 to self-associate and bind procaspase-9 independent of cytochrome c, though still requiring dATP/ATP for these activities. The Apaf-1M368L mutant exhibited greater ability to induce apoptosis compared with the wild-type Apaf-1. We also show that procaspase-9 can recruit procaspase-3 to the Apaf-1-procaspase-9 complex. Apaf-1(1-570), a mutant lacking the WD-40 repeats, associated with and activated procaspase-9, but failed to recruit procaspase-3 and induce apoptosis. These results suggest that the WD-40 repeats may be involved in procaspase-9-mediated procaspase-3 recruitment. These studies elucidate biochemical steps required for Apaf-1 to activate procaspase-9 and induce apoptosis.
Introduction
Programmed cell death, or apoptosis, an evolutionarily conserved and genetically regulated biological process, plays a critical role in the development and the regulation of tissue homeostasis of multicellular organisms (Thompson, 1995; Yuan, 1996) . Genetic analyses of the nematode Caenorhabditis elegans have identified two genes, ced-3 and ced-4, required for the execution of cell death in the worm (Hengartner and Horvitz, 1994) . The product of ced-3 is homologous to mammalian interleukin-1β-converting enzyme, a finding that provided the first indication that cysteine proteases are critical components of the cell death machinery (Miura et al., 1993) . These observations led to the identification of a growing family of cysteine proteases (designated as 3586 © European Molecular Biology Organization caspases) related to CED-3 that represent the executionary arm of the apoptotic program in mammals, flies and nematodes (Núñez et al., 1998; Thornberry and Labzenik, 1998) . Caspases are synthesized in cells as inactive precursors which upon stimulation with apoptotic signals are processed into mature forms composed of a tetramer of two large and two small subunits (Thornberry et al., 1992; Walker et al., 1994; Rotonda et al., 1996) . The apoptotic process is characterized by the proteolytic cascade in which upstream (initiator) caspases mediate the activation of downstrean (effector) caspases (Alnemri, 1997; Núñez et al., 1998) . Initiator caspases contain death effector domains (DEDs) or caspase recruitment domains (CARDs) that physically link these proteases to regulatory molecules via homophilic interactions (Li et al., 1997; Pan et al., 1998) . Caspase-9 is an upstream caspase that contains a CARD in its N-terminus; a protein module that is also present in the prodomain of several death proteases, including CED-3 and its regulator CED-4 . Activation of caspase-9 initiates a protease cascade that subsequently activates downstream caspase-3 and caspase-7, leading to the cleavage of target proteins and the orderly demise of the cell (Li et al., 1997; Sun et al., 1999) .
Our understanding of how caspases are activated in mammalian cells has been greatly enhanced by biochemical studies of the nematode proteins CED-3, CED-4 and CED-9. CED-4 physically interacts with both CED-3 and CED-9, forming a multimeric protein complex (Chinnaiyan et al., 1997; Irmler et al., 1997; James et al., 1997; Spector et al., 1997; Wu et al., 1997a,b) . CED-4 promotes the activation of CED-3 and this activation process is inhibited by CED-9 (Seshagiri and Miller, 1997; Wu et al., 1997b) . Biochemical experiments have suggested that a mechanism exists whereby CED-3 is activated through oligomerization of CED-4 (Yang et al., 1998) . Activation of CED-3 is induced through aggregation of precursor CED-3 molecules, an event leading to CED-3 autoprocessing and enzymatic activation (Yang et al., 1998) .
Apaf-1, a mammalian homologue of CED-4, has been identified recently (Zou et al., 1997; Fearnhead et al., 1998) . The N-terminal half of Apaf-1 shares extensive homology with CED-4, containing a CARD followed by an ATPase domain with conserved Walker's A and B motifs (Zou et al., 1997) . The C-terminal region of Apaf-1 lacks homology with CED-4 and consists of 12 WD-40 repeats. An important role for Apaf-1 in the regulation of apoptosis has been revealed by analysis of mutant mice deficient in Apaf-1. Mice lacking Apaf-1 showed abnormalities in several tissues characterized by the lack of developmental cell death, particularly in brain tissue (Cecconi et al., 1998; Yoshida et al., 1998) . Furthermore, cells derived from Apaf-1-deficient mice showed resist-ance to a wide variety of apoptotic stimuli, including chemotherapy drugs, dexamethasone and γ-irradiation (Yoshida et al., 1998) . In the presence of cytochrome c and dATP, Apaf-1 adopts a conformation that can bind to procaspase-9, an event that leads to its proteolytic activation (Li et al., 1997) . A conserved mechanism similar to that proposed for CED-3 has been suggested for caspase-9 activation (Hu et al., 1998b; Srinivasula et al., 1998) . In this model, two or more caspase-9 precursors are brought together via Apaf-1 oligomerization, which is mediated by the ATPase-like domain of Apaf-1 (Hu et al., 1998b; Srinivasula et al., 1998) . Mutant analyses of Apaf-1 have suggested that the WD-40 repeat region (WDR) plays an inhibitory role in Apaf-1 function, since mutants lacking the WDR are constitutively active (Hu et al., 1998a,b; Srinivasula et al., 1998) . Furthermore, the WDR has been shown to interact with the ATPase-like domain of Apaf-1, inhibiting Apaf-1 self-association. This finding suggests the existence of a mechanism whereby the WDR inhibits Apaf-1 activity (Hu et al., 1998b) .
In these studies, we sought to understand further the biochemical mechanism by which Apaf-1 promotes the maturation of procaspase-9 into an active protease. Analysis of wild-type (wt) and mutant Apaf-1 proteins revealed that dATP/ATP hydrolysis is required for cytochrome c binding to Apaf-1, Apaf-1 self-association, interaction of Apaf-1 with procaspase-9, and ultimately for caspase-9 activation and caspase-9-mediated apoptosis. We also provide evidence that the Apaf-1-caspase-9 complex recruits procaspase-3, a process that may be regulated by the WDR of Apaf-1.
Results
Identification of Apaf-1XL, an alternatively spliced Apaf-1 cDNA that activates procaspase-9 In our initial studies of Apaf-1-mediated caspase-9 activation, we determined that procaspase-9 could be efficiently activated by endogenous Apaf-1 from several cell lines including HeLa and 293T cells (Hu et al., 1998a ; data not shown). We subsequently identified Apaf-1 cDNAs from these two cell lines. An Apaf-1 cDNA cloned from HeLa cells was identical to that previously reported (Zou et al., 1997) . However, the Apaf-1 cDNA cloned from 293T cells appeared to represent an alternatively spliced form of the Apaf-1 gene. This form, termed Apaf-1XL, contains an 11 amino acid (aa) insertion, GKDSVSGITSY, after the CARD (inserted between amino acids 98 and 99), and another 43 aa insertion between amino acids 811 and 812 ( Figure 1A ). This 43 aa region contains the last three amino acids of a WD-40 repeat followed by a large portion of another WD-40 repeat, thus creating an additional WD-40 repeat ( Figure 1A) . The sequence of these extra 43 aa is identical to that present in a truncated human Apaf-1 cDNA submitted to databases (DDBJ/ EMBL/GenBank accession No. AB007873). Moreover, a mouse Apaf-1 cDNA isolated from brain tissue also contained this additional WD-40 repeat (Cecconi et al., 1998) . In addition, a recent study has identified an Apaf-1 form in HeLa cells that is identical to Apaf-1XL (Zou et al., 1999) . Using reverse transcriptase (RT)-PCR and Western blotting analysis, we have identified both Apaf-1XL mRNA and protein in 16 cell lines tested so far (data 3587 not shown). Under our experimental conditions, Apaf-1XL protein expressed in 293T cells activated procaspase-9 in a cytochrome c-and dATP-dependent manner ( Figure 1D ). Under the same conditions, we were unable to demonstrate cytochrome c-and dATP-dependent procaspase-9 activation by the product of the original Apaf-1 cDNA (data not shown). Therefore, in the present studies we used the Apaf-1XL cDNA to examine the mechanism by which Apaf-1 activates procaspase-9 and refer to it as Apaf-1 for simplicity.
Mutation of Met368 to Leu enables full-length
Apaf-1 to activate procaspase-9 independently of cytochrome c and dATP We demonstrated previously that the WDR interacts with the N-terminal CED-4 homologous region of Apaf-1 and inhibits procaspase-9 activation when co-expressed with the constitutively active N-terminal Apaf-1 mutants (Hu et al., 1998b) . We performed experiments to determine whether the WDR with an extra WD-40 repeat is also capable of binding to N-terminal Apaf-1 with an 11 aa insertion [Apaf-1(1-570)] and inhibiting procaspase-9 activation. The analyses showed that the WDR containing the extra WD-40 repeat associated with Apaf-1(1-570) ( Figure 1B ) and inhibited procaspase-9 activation promoted by Apaf-1(1-570) ( Figure 1C ). To understand further how Apaf-1 promotes procaspase-9 activation, we tested several Apaf-1 N-terminal mutants accumulated during PCR mutagenesis for their ability to interact with the WDR. A mutant substituting amino acid Met368 for Leu, Apaf-1(1-570M368L), showed a reduced ability to bind the WDR ( Figure 1B ), but it retained its ability to promote procaspase-9 activation independent of cytochrome c and dATP ( Figure 1C) . In contrast to Apaf-1(1-570), however, the ability of Apaf-1(1-570M368L) to induce procaspase-9 activation was not inhibited by the WDR ( Figure 1C ). We next incorporated the M368L point mutation into full-length Apaf-1 and determined the ability of wt and mutant Apaf-1 to activate procaspase-9. In these experiments, we prepared cell extracts from 293T cells transiently transfected with Apaf-1 constructs and diluted the extracts so that endogenous Apaf-1 activity could not be detected in the procaspase-9 activation assay. Full-length Apaf-1 induced activation of procaspase-9 in a dATP-and cytochrome cdependent manner ( Figure 1D ). In contrast, the point mutant Apaf-1M368L activated procaspase-9 independent of cytochrome c and dATP ( Figure 1D ). Apaf-1K160R, a mutant substituting Lys160 [an essential amino acid residue in the phosphate-binding loop (P-loop)] for Arg, failed to activate procaspase-9 in the presence or absence of dATP and cytochrome c ( Figure 1D ). This result confirmed previous observations that dATP/ATP hydrolysis is required for Apaf-1 to induce procaspase-9 activation (Li et al., 1997) .
The cytochrome c-Apaf-1 interaction requires ATP hydrolysis To determine the role for cytochrome c in procaspase-9 activation, we immunoprecipitated wt and mutant Apaf-1 from cytosolic extracts in the presence or absence of dATP and assessed the binding of cytochrome c to Apaf-1 proteins by immunoblotting. Cytochrome c bound to Cytosolic extracts containing Myc-tagged Apaf-1, Apaf-1M368L or Apaf-1M368L/K160R were incubated with 10 μg/ml cytochrome c with or without 1 mM dATP or ATP-γS in the presence of monoclonal anti-Myc and protein A/G-agarose beads. After incubation at 4°C for 2 h, immunoprecipitation was performed as described in Materials and methods and cytochrome c associated with Apaf-1 proteins detected by immunoblotting. Wt and mutant Apaf-1 proteins precipitated from cytosolic extracts are shown in the lower panel.
Apaf-1, and this binding was greatly enhanced by the presence of dATP in the extract. Incubation of the extracts with the non-hydrolyzable ATP-γS completely abolished cytochrome c binding to wt Apaf-1, indicating that dATP/ATP hydrolysis is essential for Apaf-1 to interact with cytochrome c (Figure 2 ). The weak binding of cytochrome c to Apaf-1 detected in the absence of dATP is presumably due to low levels of endogenous dATP/ ATP in the cell extract. In contrast, cytochrome c interacted with Apaf-1M368L in the presence or absence of dATP ( Apaf-1 self-association requires dATP/ATP hydrolysis It was previously reported that Apaf-1 requires dATP/ATP to activate procaspase-9 (Li et al., 1997) . dATP/ATP hydrolysis could be required for Apaf-1 self-association and/or the Apaf-1-procaspase-9 interaction, since a disrup- The experiments were performed as in (A) except that Apaf-1(1-570)-FLAG-containing extracts were mixed with lysates containing Apaf-1, Apaf-1M368L, Apaf-1K160R, or Apaf-1M368L/K160R. Expression of wt and mutant Apaf-1 proteins in total lysates is shown in lower panels. (C) Apaf-1M368L can associate with Apaf-1(1-570) independent of cytochrome c and dATP. Constructs producing Apaf-1(1-570) and Apaf-1M368L were cotransfected into 293T cells and prepared total lysates were used for immunoprecipitation as described in (A).
tion of either step might be sufficient to inhibit procaspase-9 activation (Hu et al., 1998b; Srinivasula et al., 1998) . We first determined whether dATP/ATP hydrolysis is required for Apaf-1 self-association in cytosolic extracts. We transiently transfected 293T cells with a Myc-tagged Apaf-1(1-570) construct and assessed its interaction with endogenous Apaf-1 in the absence of detergent. Immunoprecipitation experiments showed that endogenous Apaf-1 associated with Apaf-1(1-570) in the presence of cytochrome c and dATP, but not in the absence of these factors ( Figure 3A) . The non-hydrolyzable ATP analogue, ATP-γS, failed to substitute for dATP ( Figure 3A ), indicating that ATP hydrolysis rather than simple ATP binding is required for Apaf-1 to self-associate. We next prepared extracts from cells transfected with wt and mutant Apaf-1 constructs to analyze further the requirement of dATP and/or cytochrome c for Apaf-1 selfassociation. Immunoprecipitation analysis showed that Apaf-1 self-association required both cytochrome c and dATP ( Figure 3B ), in agreement with the results obtained with endogenous Apaf-1. The constitutively active Apaf-1M368L mutant associated with Apaf-1 in the absence of cytochrome c, but required dATP for association with Apaf-1(1-570) ( Figure 3B ). Mutation of the critical P-loop Lys160 to Arg (M368L/K160R) abolished the ability of Apaf-1M368L to associate with Apaf-1 ( Figure 3B ). When co-expressed with Apaf-1(1-570), Apaf-1M368L interacted with Apaf-1(1-570) without the addition of exogenous dATP ( Figure 3C ), suggesting that intracellular dATP/ATP can promote their association.
Procaspase-9 binding to Apaf-1 requires dATP/ATP hydrolysis To examine the role of dATP/ATP hydrolysis in procaspase-9 binding, we first determined whether dATP/
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ATP binding/hydrolysis is required for endogenous Apaf-1 to bind procaspase-9 in cytosolic extracts. We began by transiently transfecting 293T cells with hemagglutinin (HA)-tagged procaspase-9 (C287S) and assessing the interaction of procaspase-9 with endogenous Apaf-1 in the absence of detergent. Immunoprecipitation of procaspase-9 showed that endogenous Apaf-1 binds to procaspase-9 in the presence of cytochrome c and dATP, but not in the absence of these factors ( Figure 4A ). In addition, the non-hydrolyzable ATP analogue, ATP-γS, inhibited procaspase-9 binding to endogenous Apaf-1 ( Figure 4A ), indicating that ATP hydrolysis is required for Apaf-1 to bind procaspase-9. We next performed immunoprecipitations with cytosolic extracts from cells transfected with wt and mutant Apaf-1 constructs to further dissect the requirement of dATP and/or cytochrome c for the binding of procaspase-9 to Apaf-1. To avoid the formation of Apaf-1 protein complexes in living cells, we prepared cellular extracts expressing wt or mutant Apaf-1 and incubated them with separately prepared extracts containing procaspase-9 (C287S). As we showed with endogenous Apaf-1, exogenous Apaf-1 required both cytochrome c and dATP to interact with procaspase-9 ( Figure 4B ). Mutation of Lys160 to Arg abolished procaspase-9 binding to Apaf-1, confirming that dATP/ ATP hydrolysis is needed for the Apaf-1-procaspase-9 interaction. The constitutively active Apaf-1M368L mutant interacted with procaspase-9 in the absence of dATP and cytochrome c ( Figure 4B ), which is consistent with the observation that this mutant does not require these factors for activation of procaspase-9. Furthermore, in contrast to endogenous Apaf-1, incubation with ATP-γS did not inhibit the binding of mutant Apaf-1M368L to procaspase-9 (data not shown). Surprisingly, mutation of Lys160 to Arg abolished the ability of Apaf-1M368L to interact with procaspase-9 ( Figure 4C ), suggesting that dATP/ATP binding/hydrolysis is indeed required for this point mutant to associate with procaspase-9. These apparently conflicting data for the dATP/ATP requirement are probably explained by the pre-formation of Apaf-1M368L oligomeric complex within the cell after exposure to endogenous dATP/ATP. ATP hydrolysis is only required for a brief period of time for Apaf-1 to activate procaspase-9 Next we performed experiments to determine whether dATP/ATP hydrolysis is continuously required for Apaf-1-mediated activation of procaspase-9. To do this, we added the non-hydrolyzable ATP analog, ATP-γS, to the procaspase-9 activation assay at various times, incubating the reaction for a total of 30 min. As depicted in Figure 5 , procaspase-9 activation was greatly inhibited by ATP-γS when added at the beginning of the reaction. ATP-γS inhibited procaspase-9 activation by~70% when added after 10 s and by~30% after 20 s ( Figure 5 ). ATP-γS minimally inhibited or could no longer inhibit procaspase-9 activation when it was added after 40 s (Figures 5). These experiments suggest that dATP/ATP hydrolysis is required for a brief period of time to activate procaspase-9. 5 . dATP hydrolysis is only required for a short time in Apaf-1-mediated procaspase-9 activation. Two micrograms of Apaf-1-containing extract was mixed with 1 μl [ 35 S]methionine-labeled procaspase-9 on ice in the presence of 0.1 mM dATP and 0.2 μg of cytochrome c. One millimolar ATP-γS was added to the reaction mixture at different time intervals after the tubes containing reaction mixtures were transferred into 30°C waterbath. The reaction was incubated for a total of 30 min at 30°C. (A) Procaspase-9 activation profile in the presence of ATP-γS when added at different times after the beginning of the reactions. (B) Time course of inhibition of procaspase-9 processing by ATP-γS. The amount of unprocessed and processed caspase-9 (p35) forms were scanned and quantitated using a phosphoimager. First, the amount of p35 processed forms was normalized to full-length procaspase-9 and added to the corresponding unprocessed procaspase-9 to obtain the total amount of procaspase-9 used in each lane. Then, p35 bands were normalized relative to total procaspase-9 in each lane. Finally, normalized p35 fragments were divided by the p35 fragment without ATP-γS (positive control).
Apaf-1M368L exhibits enhanced ability to induce apoptosis
The experiments shown in Figure 1D indicate that the Apaf-1M368L mutant can activate procaspase-9 independently of cytochrome c. To determine the significance of these findings for induction of apoptosis, we transiently transfected wt and mutant Apaf-1 constructs into 293T cells and assessed their ability to induce apoptosis 19 h after transfection. Wt Apaf-1 failed to induce cell death at low concentrations, but induced low-level apoptosis at higher concentrations of plasmid DNA (Figure 6 ). In contrast, Apaf-1M368L induced significant apoptosis even at low levels of plasmid DNA and exhibited greater proapoptotic activity than wt Apaf-1 at higher levels of plasmid ( Figure 6B ). The P-loop mutant of Apaf-1 (K160R) deficient in Apaf-1 self-association and procaspase-9 binding failed to induce apoptosis at all concentrations of plasmid tested ( Figure 6B ). Apaf-1M368L-induced apoptosis was effectively inhibited by a catalytically inactive caspase-9 mutant (C287S) that acts as a dominant-negative inhibitor ( Figure 6B ) (Li et al., 1997; Pan et al., 1998) , indicating that apoptosis induced by Apaf-1M368L is caspase-9 dependent. Significantly, the Apaf-1 double mutant, M368L/K160R, did not induce apoptosis consistent with a requirement of dATP/ATP hydrolysis for Apaf-1M168L to self-associate and binding to procaspase-9 ( Figure 6C ). 
Apaf-1(1-570) fails to induce apoptosis and activate procaspase-3
Like the Apaf-1M368L mutant, Apaf-1 mutants lacking the WDR can activate procaspase-9 independent of cytochrome c and dATP ( Figure 1C ) (Hu et al., 1998a,b; Srinivasula et al., 1998) . Therefore, we compared the ability of Apaf-1M368L and Apaf-1(1-570) to induce apoptosis. Significantly, Apaf-1(1-570) did not kill 293T cells while Apaf-1M368L induced significant apoptosis in transfected cells ( Figure 7A ). Immunoblotting analysis with anti-caspase-9 antibody showed that both Apaf-1M368L and Apaf-1(1-570) induced processing of endogenous procaspase-9 into its signature p35 fragment ( Figure 7B, upper panel) , indicating that the differential activity of these Apaf-1 mutants cannot be explained by lack of procaspase-9 activation. To assess the activation of procaspase-3, a downstream caspase activated by caspase-9, we immunoblotted the same extracts with anticaspase-3 antibody. Expression of Apaf-1M368L induced processing of procaspase-3, as determined by the appearance of the p18 subunit and reduction of procaspase-3 levels ( Figure 7B , lower panel, reduced levels of procaspase-3 could be observed in a shorter exposure; data not shown). Significantly, procaspase-3 from cells transfected with Apaf-1(1-570) remained unprocessed even though procaspase-9 was cleaved ( Figure 7B) . Thus, the differential proapoptotic activity exhibited by the constitutively active Apaf-1 mutants, Apaf-1(1-570) and Apaf-1M368L, might be explained by the differential processing of procaspase-3. To gain more insight into this mechanism, we further assessed the activation of procaspase-3 and procaspase-9 in cytosolic extracts prepared from Apaf-1M368L and Apaf-1(1-570)-transfected cells. In Apaf-1M368L extracts, procaspase-9 could be effectively processed into the signature p35 proteolytic fragment resulting from autoactivation of procaspase-9 and p37, a fragment resulting from cleavage of procaspase-9 by active caspase-3 ( Figure 7C , upper panel) (Srinivasula et al., 1998) . In contrast, procaspase-9 was only cleaved into p35 but not p37 in the Apaf-1(1-570) extract ( Figure  7C ), providing additional evidence that caspase-3 was not activated in extracts expressing Apaf-1(1-570). To verify this result, we assessed the processing of procaspase-3 in the same extracts. The analysis confirmed that Apaf-1M368L but not Apaf-1(1-570) promoted procaspase-3 activation ( Figure 7C , lower panel). -1(1-570) can recruit procaspase-3 to the Apaf-1-procaspase-9 complex through procaspase-9 Next we wanted to determine the mechanism by which procaspase-3 is activated in extracts from Apaf-1M368L transfected cells but not from those expressing Apaf-1(1-570). One possibility we considered is that procaspase-3 could be recruited to the Apaf-1M368L-procaspase-9 complex but not to the Apaf-1(1-570)-procaspase-9 complex. To examine this, we immobilized various Apaf-1 mutants on agarose beads in the presence or absence of procaspase-9 and incubated the immobilized Apaf-1 or Apaf-1-procaspase-9 complexes with in vitro translated procaspase-3. In the absence of procaspase-9 (C2827S), procaspase-3 interacted weakly with Apaf-1M368L, while procaspase-3 did not associate with Apaf-1(1-570) or Apaf-1(479-1248) ( Figure 8A ). The presence of procaspase-9 greatly enhanced the binding of procaspase-3 to Apaf-1M368L ( Figure 8A ). In contrast, procaspase-3 did not bind to Apaf-1(1-570) even in the presence of procaspase-9 ( Figure 8A ). To determine whether procaspase-3 interacts with procaspase-9 alone 3592 Fig. 8 . Procaspase-3 is recruited into the Apaf-1-caspase-9 complex but not into the Apaf-1(1-570)-caspase-9 complex. (A) Procaspase-3 is recruited into Apaf-1M368L-caspase-9 complex. Apaf-1 proteins were immobilized on agarose beads and packed into gel filtration columns as described in Materials and methods. In vitro-translated [ 35 S]methionine-labeled procaspase-3 was loaded onto the beads. After extensive washing proteins bound to the beads were eluted, separated by SDS-PAGE and transferred to nitrocellulose membrane. (B) Procaspase-3 binds to procaspase-9 directly. Experiments were performed as in (A) except procaspase-9 (C287S) was immobilized on agarose beads. Procaspase-3 bound was detected by autoradiography and Apaf-1 proteins and procaspase-9 (C287S) were detected by immunoblotting. The upper panels show an autoradiograph of procaspase-3 bound and amounts of bound procaspase-3 as quantitated with a phosphoimager (procaspase-3 bound to control beads was arbitrarily designated as 1). Apaf-1 proteins and procaspase-9 (C287S) bound to beads were shown in lower two panels. Asterisks indicate non-specific bands. H, immunoglobulin heavy chain; Cont., control lysates transfected with pcDNA3.
Apaf-1M368L but not Apaf
or with the Apaf-1M368L-procaspase-9 complex, we performed similar experiments with immobilized procaspase-9 ( Figure 8B ). As shown in Figure 8B , procaspase-3 did bind to procaspase-9 in the absence of Apaf-1. Addition of Apaf-1M368L or wt Apaf-1 in the presence of cytochrome c and dATP enhanced the binding of procaspase-3 to immobilized procaspase-9 by 2-to 4-fold ( Figure 8B ). This effect is presumably due to increased recruitment of procaspase-9 to the complex by binding to Apaf-1M368L or Apaf-1 in the presence of cytochrome c and dATP. A direct interaction between procaspase-3 and procaspase-9 was also confirmed by co-immunoprecipitation analysis (data not shown). Thus, wt Apaf-1 and Apaf-1M368L but not Apaf-1(1-570) can recruit procaspase-3 to the Apaf-1-procaspase-9 complex through procaspase-9. Fig. 9 . A model depicting the mechanism of apoptosome formation and procaspase-9 activation. Apaf-1 undergoes sequential conformational changes induced by ATP hydrolysis and cytochrome c binding and acquires the ability to oligomerize. Subsequent binding of procaspase-9 to the Apaf-1 oligomer results in recruitment of procaspase-3 and possibly procaspase-7 to this complex to form a functional apoptosome. Apaf-1M368L may bypass the first two steps and adopts a conformation that is competent in oligomerizing and binding to procaspase-9 in the presence of dATP. Alternatively, Apaf-1M368L may assume a conformation that bypasses cytochrome c binding but still requires a single dATP/ATP hydrolysis event for oligomerization and procaspase-9 binding. This model is presented in greater detail in the Discussion.
Discussion
In this report we used Apaf-1 and various mutants to elucidate the mechanism by which Apaf-1 mediates procaspase-9 activation and induces apoptosis. Our studies revealed that the binding of cytochrome c to Apaf-1 requires dATP/ATP hydrolysis. We also demonstrated that two essential steps involved in procaspase-9 activation, Apaf-1 self-association and procaspase-9 recruitment to Apaf-1, require dATP/ATP hydrolysis and cytochrome c binding to Apaf-1. These steps are important for proapoptotic activity since Apaf-1 mutants deficient in dATP/ATP hydrolysis or cytochrome c binding are impaired in their ability to promote procaspase-9 activation and apoptosis. Finally, we provide evidence that procaspase-3 is recruited into the Apaf-1-procaspase-9 complex via interaction with procaspase-9. The WDR may play an important role in the recruitment of procaspase-3 to the Apaf-1-procaspase-9 complex, since mutant Apaf-1(1-570) lacking the WDR can bind to procaspase-9 but cannot recruit procaspase-3 and is deficient in apoptosis.
Our observations that the WDR with an extra WD-40 repeat can interact with Apaf-1(1-570) and inhibit activation of procaspase-9 mediated by Apaf-1(1-570) ( Figure 1B and C) support conclusions of our previous paper obtained with the original Apaf-1 cDNA clone (Hu et al., 1998b) . Based on the results of our present study and previous studies (Hu et al., 1998b; Srinivasula et al., 1998) , we provide a model depicting the events that lead to the formation of a functional apoptosome (Figure 9 ). In this model, dATP/ATP hydrolysis induces a conformational change so that Apaf-1 acquires the ability to bind cytochrome c. Upon cytochrome c binding, Apaf-1 undergoes further conformational changes to allow Apaf-1 oligomerization and CARD exposure. Procaspase-9 is then recruited into Apaf-1 oligomers via CARD-CARD homophilic interactions, and procaspase-3 is recruited into the complex via interaction with procaspase-9. Once recruited to the apoptosome, procaspase-9 is activated via autocatalysis by Apaf-1 oligomerizationinduced proximity of multiple procaspase-9 molecules (Hu et al., 1998b; Srinivasula et al., 1998) . Procaspase-9 might be cleaved and activated by adjacent procaspase-9 molecules (intermolecular catalysis). Alternatively, procaspase-9, forming part of the apoptosome, might adopt a conformation that results in intramolecular cleavage. Activated caspase-9 then cleaves and activates procaspase-3 recruited to the apoptosome. Once the functional apoptosome is formed, dATP/ATP hydrolysis would not longer be required for procaspase-9 recruitment, activation or release of active caspase-9, as suggested by our finding that dATP/ATP hydrolysis is only required for a brief period of time in order for Apaf-1 to activate procaspase-9. A model of Apaf-1 function that is consistent with our findings has been proposed recently based on studies with purified Apaf-1 and procaspase-9 proteins (Zou et al., 1999) .
In this study, we generated and characterized an Apaf-1 mutant that activates procaspase-9 independent of cytochrome c. Apaf-1M368L constitutively self-associates when synthesized in living cells. However, additional mutation of Lys160 to Arg abrogated its ability to selfassociate and bind procaspase-9, as well as its capacity to promote procaspase-9 activation and apoptosis. Although the precise mechanism that accounts for its constitutional activation remains to be determined, these results suggest that Apaf-1M368L may bind and hydrolyze dATP/ATP in vivo, and induce Apaf-1 oligomerization and procaspasebinding and activation as intracellular dATP or ATP levels are available in cells at concentrations of 10 μM and 10 mM, respectively (Skoog and Bjursell, 1974) . The ability of Apaf-1 to bind and hydrolyze dATP/ATP was demonstrated by a recent paper that was published while this paper was under review (Zou et al., 1999) . In the absence of dATP/ATP hydrolysis, the ability of wt Apaf-1 to oligomerize and to bind procaspase-9 might be repressed by an interaction between its N-terminal region and the WDR ( Figure 1B and C) (Hu et al., 1998b) . One role of dATP/ATP hydrolysis might be to induce a conformational change that enables cytochrome c to bind Apaf-1. This hypothesis is supported by our finding that cytochrome c binding to Apaf-1 requires dATP/ATP hydrolysis. Binding of cytochrome c to the WDR may disrupt or alter the negative interaction between the N-terminal region and the WDR, allowing Apaf-1 to oligomerize and to bind procaspase-9. This model is supported by the analysis of the Apaf-1M368L mutant. This mutant exhibited reduced interaction between the Nterminal region and the WDR, bypassing the requirement of cytochrome c to disrupt the negative interaction. The lack of requirement for cytochrome c suggests that Apaf-1M368L spontaneously adopts a conformation that is competent for oligomerization and procaspase-9 binding in the presence of dATP/ATP. Mutation of Met368 to Leu, therefore, might mimic conformational changes induced by dATP hydrolysis and cytochrome c binding. Thus, our findings that Apaf-1M368L still requires dATP/ATP binding or hydrolysis suggest that a second dATP/ATP binding or hydrolysis event may be required. Alternatively, Apaf-1M368L may assume a conformation that bypasses cytochrome c binding but still requires a single dATP/ ATP hydrolysis event for oligomerization and procaspase-9 binding. CED-4, the C.elegans homologue of Apaf-1, lacks the WDR implying that CED-4 could constitutively activate CED-3, unless repressed by its physical association with CED-9. This model is supported by genetic analysis of C.elegans that showed that loss-of-function mutants of ced-9 are lethal due to increased developmental cell deaths, but can be rescued by loss-of-function mutations in ced-4 (Hengartner et al., 1992) . Furthermore, biochemical experiments in mammalian cells have revealed that the ability of CED-4 to activate CED-3 is inhibited by the association of CED-9 with CED-4 (Seshagiri and Miller, 1997; Wu et al., 1997b) . Interestingly, the equivalent position of Met368 is conserved in mouse Apaf-1 but is a leucine residue in CED-4. These observations suggest that cytochrome c is probably not a factor required for CED-4-mediated CED-3 activation. However, additional studies to test this hypothesis need to be performed in C.elegans.
Apaf-1M368L acts as a gain-of-function mutation in that, unlike wt Apaf-1, it activates procaspase-9 independent of cytochrome c and dATP in vitro and exhibits enhanced ability to induce apoptosis in vivo. In contrast, another mutant, Apaf-1(1-570), activates procaspase-9 independent of cytochrome c and dATP in vitro, but fails to induce apoptosis. Our results indicate that procaspase-9 complexed with Apaf-1M368L, but not procaspase-9 complexed with Apaf-1(1-570), can recruit and activate procaspase-3, providing an explanation for the differential phenotypes. Our studies support a model whereby procaspase-3 is recruited into the apoptosome formed by the Apaf-1-procaspase-9 complex via its interaction with procaspase-9. Apaf-1(1-570) lacking the WDR binds and activates procaspase-9 suggesting that its inability to recruit procaspase-3 is independent of these activities. Several possibilities could be envisioned to explain these results. First, conformational changes in the procaspase-9 bound to wt Apaf-1 and Apaf-1M368L could be critical for the recruitment of procaspase-3. Procaspase-9 bound to Apaf-1(1-570) might assume a conformation that is unsuitable for procaspase-3 recruitment. Another possibility is that the WDR, which is lacking in Apaf-1 (1-570), might be involved in the recruitment of procaspase-3 to the Apaf-1-procaspase-9 complex. In the absence of the WDR, Apaf-1(1-570) may be unable to induce the conformational changes of procaspase-9 required for recruitment of procaspase-3.
The cytochrome c/Apaf-1/caspase-9/caspase-3 pathway is now known to contribute to apoptosis induced by various stresses, including UV and γ-irradiation and chemotherapeutic drugs Yoshida et al., 1998) . In addition, inactivation of either Apaf-1 or caspase-9 in this pathway contributes to cellular trans-3594 formation and tumorigenesis (Soengas et al., 1999) . Under normal conditions, cytochrome c is unavailable to induce procaspase-9 activation since it resides in the intermembrane space of the mitochondria. After apoptotic stimuli lead to mitochondrial damage, cytochrome c is released and can activate procaspase-9 in an Apaf-1-dependent manner (Zou et al., 1997; Fearnhead et al., 1998) . Prosurvival Bcl-2 family members are overexpressed in many tumors and inhibit caspase-9-mediated apoptosis by binding and inhibiting procaspase-9 activation directly and/or preventing the release of cytochrome c from mitochondria (Kharbanda et al., 1997; Kim et al., 1997; Kluck et al., 1997; Yang et al., 1997; Hu et al., 1998a) . Therefore, it will be interesting to examine whether prosurvival Bcl-2 family members like Bcl-X L can directly inhibit Apaf-1M368L-mediated procaspase-9 activation. If Bcl-X L can no longer exert its inhibitory effect on Apaf-1M368L-mediated activation of procaspase-9, the ability of Apaf-1M368L to activate procaspase-9 in the absence of cytochrome c could provide a potential method of inducing apoptosis in cancer cells in which cytochrome c release is blocked by overexpression of anti-apoptotic members of the Bcl-2 family.
Materials and methods

Plasmids and reagents
The Apaf-1XL cDNA was isolated by RT-PCR amplification from RNA template isolated from 293T cells and cloned into the pcDNA3 plasmid. The nucleotide sequence of the Apaf-1XL cDNA has been submitted to the DDBJ/EMBL/GenBank database (accession No. AF149794). pcDNA3-Apaf-1XL-M368L and pcDNA3-Apaf-1XL-K160R were generated by replacing the BstEII-EcoRV fragment of pcDNA3-Apaf-1XL with the corresponding fragments from pcDNA3-Apaf-1(1-559M357L) and pcDNA3-Apaf-1(1-559K149R), respectively (Hu et al., 1998b) . pcDNA3-Apaf-1XL-M368L/K160R was constructed by ligation of a BstEII-XbaI fragment from pcDNA3-Apaf-1(1-559K149R) and a XbaIEcoRV fragment from pcDNA3-Apaf-1(1-559M357L) into BstEIIEcoRV-digested pcDNA3-Apaf-1XL. All the constructs were verified by nucleotide sequencing. Polyclonal anti-Apaf-1 antibody was kindly provided by Xiaodong Wang, Southwestern Medical School, Dallas, TX. Polyclonal anti-caspase-9 and anti-caspase-3 antibodies were gifts from Donald Nicholson (Merck).
Transfection, immunoprecipitation and Western blot analysis
Human embryonic kidney 293T cells (2-5ϫ10 6 ) were transfected with 5 μg of the indicated plasmid DNA by the calcium phosphate method as reported (Inohara et al., 1997) . Cytosolic extracts were made essentially as described previously (Hu et al., 1998a) . Protein immunoprecipitation and Western blot analysis with relevant antibodies were performed as described previously (Inohara et al., 1997) . The proteins were detected by an enhanced chemiluminescence system (ECL; Amersham).
In vitro caspase-9 and caspase-3 assay Cytosolic extracts were prepared and stored frozen at -80°C. Procaspase-9 was translated in vitro from a pcDNA3-caspase-9 plasmid in the presence of [ 35 S]methionine (Amersham) with a Promega TNT transcription/translation kit and purified through a desalting column free of radioactive methionine and ATP (Pharmacia). Procaspase-3 was translated in vitro using the same kit. To avoid contaminating dATP/ ATP from cytosolic extracts in testing cytochrome c and dATP-dependent activation of procaspase-9 by Apaf-1 proteins, the cytosolic extracts were passed through a desalting column (Pharmacia). We incubated 2 μg ( Figures 1D and 5A ) or 40 μg ( Figure 7C ) of cellular extracts with or without dATP (1 mM) or bovine cytochrome c (0.2 μg, Sigma) in the presence of 1 μl in vitro translated procaspase-9 in a final volume of 25 μl. The mixtures were incubated for 30 min at 30°C and the reactions stopped by adding 5ϫ SDS loading buffer and boiling for 5 min. 293T cells (1ϫ10 5 ) were seeded in each well of 12-well plates. After 18 h, cells were transiently transfected with 0.2 μg of the reporter pcDNA3-galactosidase plasmid plus indicated amount of test plasmids, as reported (Hu et al., 1998a) . pcDNA3 was used to adjust total plasmid DNA to an equal amount. The percentage of apoptotic cells was determined 19 h after transfection in triplicate cultures as described previously (Hu et al., 1998a) .
Apoptosis assay
Procaspase-3 recruitment assay
Cytosolic extracts containing Myc-tagged Apaf-1 proteins and control or caspase-9 extracts were incubated with either anti-c-Myc (to immobilize Apaf-1 protein) or anti-HA (to immobilize procaspase-9) antibodies and protein A/G-agarose beads (1:1) for 2 h. The beads were washed three times with 1 ml NP-40 buffer (Inohara et al., 1997) and once with 1 ml buffer A (Hu et al., 1998a) . Apaf-1-or procaspase-9-coated beads were packed into disposable gel filtration columns. Then in vitro translated caspase-3 was loaded onto the beads and washed four times with 1 ml buffer A. Bound proteins were eluted with 50 μl of hot 1ϫ SDS loading buffer. We quantitated bound caspase-3 using a PhosphorImager from Molecular Dynamics.
